• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: EXACTECH, INC. NV GXL LINR, NTRL, 36MM ID, GROUP 3 CUPS; PROSTHESIS, HIP, SEMI-CONSTRAINED, METAL/POLYMER, CEMENTED

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

EXACTECH, INC. NV GXL LINR, NTRL, 36MM ID, GROUP 3 CUPS; PROSTHESIS, HIP, SEMI-CONSTRAINED, METAL/POLYMER, CEMENTED Back to Search Results
Catalog Number 130-36-53
Medical Device Problem Code Naturally Worn (2988)
Health Effect - Clinical Codes Pain (1994); Osteolysis (2377); Appropriate Clinical Signs, Symptoms and Conditions Term/Code Not Available (4581)
Date of Event 10/25/2023
Type of Reportable Event Serious Injury
Additional Manufacturer Narrative
D10: concomitant devices: (b)(6), 170-36-93 - biolox delta femoral head 36mm od, -3.5mm.(b)(6), 186-01-56 - integrip cc, cluster 56mm,g3.(b)(6), 164-13-12 - novation element ro s/o col sz 12.The product associated with the reported event is within the scope of recall z-1729-2022; however, there is insufficient information to evaluate whether the subject issue of the recall was the cause or contributor to the reported event.The device was not returned for evaluation and no medical or other records containing treatment information or patient information have been received; therefore, the reported event cannot be confirmed, nor can the circumstances or potential causes or contributors to the alleged event be evaluated.Should additional material information become available that permits more analysis or conclusions, a supplemental report will be filed accordingly.
 
Event or Problem Description
It was reported via legal documentation that approximately 83 months after a left total hip replacement procedure, the patient underwent a revision procedure to address prosthesis wear, premature, unnecessary revision surgery; tissue and bone loss.No further issues or complications were reported.No additional information is available.
 
Additional Manufacturer Narrative
H6: corrected the following: health effect clinical code, type of investigation manufacturer narrative updated: the most likely underlying cause for the revision reported is a combination of risk factors such as use error, implant positioning, implant size selection, and patient factors (fitness for surgery, biomechanics, activity level and local tissue oxidation potential).However, this cannot be confirmed from the reported information and the devices were not available for evaluation.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
NV GXL LINR, NTRL, 36MM ID, GROUP 3 CUPS
Common Device Name
PROSTHESIS, HIP, SEMI-CONSTRAINED, METAL/POLYMER, CEMENTED
Manufacturer (Section D)
EXACTECH, INC.
2320 nw 66 court
gainesville FL 32653
Manufacturer (Section G)
EXACTECH, INC
2320 nw 66th court
gainesville FL 32653
Manufacturer Contact
geoff gannon
2320 nw 66th court
gainesville, FL 32653
3523771140
MDR Report Key19731604
Report Number1038671-2024-02379
Device Sequence Number8206403
Product Code JDI
UDI-Device Identifier10885862022233
UDI-Public10885862022233
Combination Product (Y/N)N
Initial Reporter StateFL
Initial Reporter CountryUS
PMA/510(K) Number
K070479
Number of Events Summarized1
Summary Report (Y/N)N
Device Implanted Year2016
Device Explanted Year2023
Serviced by Third Party (Y/N)N
Reporter Type Manufacturer
Report Source Consumer,Company Representative
Initial Reporter Occupation Non-Healthcare Professional
Type of Report Initial,Followup
Report Date (Section B) 11/14/2024
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Operator of Device Health Professional
Device Expiration Date04/26/2020
Device Catalogue Number130-36-53
Was Device Available for Evaluation? No
Type of Report(Section G)Thirty-Day
Initial Date Received by Manufacturer 07/11/2024
Supplement Date Received by Manufacturer11/13/2024
Initial Report FDA Received Date07/12/2024
Supplement Report FDA Received Date11/14/2024
Was Device Evaluated by Manufacturer? (Y/N) Device Not Returned to Manufacturer
Date Device Manufactured04/28/2015
Is the Device Labeled for Single Use? (Y/N) Yes
Is This a Single-Use Device that was
Reprocessed and Reused on a Patient? (Y/N)
No
Usage of Device Initial
Patient Sequence Number1
Concomitant Medical Products
and Therapy/Usage Dates
SEE H11.
Outcome Attributed to Adverse Event Hospitalization; Required Intervention;
Patient SexUnknown
-
-